BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38041848)

  • 1. Importance of CHB's grey zone: analysis of patients with HBeAg negative chronic hepatitis B virus infection.
    Lenartova PD; Hockickova I; Janicko M; Jarcuska P; Drazilova S; Lami F; Schreter I; Kristian P
    Bratisl Lek Listy; 2024; 125(1):59-63. PubMed ID: 38041848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
    Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
    World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
    Gao Y; Wang M; Liu X
    Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
    Duan M; Chi X; Xiao H; Liu X; Zhuang H
    Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.
    Ren S; Wang W; Lu J; Wang K; Ma L; Zheng Y; Zheng S; Chen X
    Front Immunol; 2022; 13():1035923. PubMed ID: 36389814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone.
    Bonacci M; Lens S; Mariño Z; Londoño MC; Rodríguez-Tajes S; Mas A; García-López M; Pérez-Del-Pulgar S; Sánchez-Tapias JM; Forns X
    Aliment Pharmacol Ther; 2018 May; 47(10):1397-1408. PubMed ID: 29577350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection.
    Barut S; Gemici Ü; Güneş F; Demir O; Duygu F
    J Med Virol; 2017 Nov; 89(11):1952-1957. PubMed ID: 28618019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
    Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
    J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone.
    Yao K; Liu J; Wang J; Yan X; Xia J; Yang Y; Wu W; Liu Y; Chen Y; Zhang Z; Li J; Huang R; Wu C
    J Viral Hepat; 2021 Jul; 28(7):1025-1033. PubMed ID: 33797145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLINICAL PHASES OF CHRONIC HEPATITIS B AMONG GEORGIAN PATIENTS.
    Zakalashvili M; Butsashvili M; Zarkua J; Abzianidze T; Kamkamidze G; Metreveli D
    Georgian Med News; 2022 Jan; (322):26-29. PubMed ID: 35134754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.
    Wang J; Yan X; Zhu L; Liu J; Qiu Y; Li Y; Liu Y; Xue R; Zhan J; Jiang S; Geng Y; Wan Y; Li M; Mao M; Gao D; Yin S; Tong X; Xia J; Ding W; Chen Y; Li J; Zhu C; Huang R; Wu C
    Aliment Pharmacol Ther; 2023 Mar; 57(5):464-474. PubMed ID: 36324235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels.
    Sanai FM; Alhouthali AH; Alghamdi HS; Badriq F; Sanai EA; Mujalled MK; Khayyat W; Attar MS; Bagadeem BS; Meer AM; Alshumrani W; Albeladi K; AlTraif I; Alqahtani S
    Saudi J Gastroenterol; 2022; 28(5):341-347. PubMed ID: 35488588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone.
    Gan QY; Wang JX; Qian F; Wang YL; Huang Y; Zhang ZL; Jiang SW; Zhang CX; Cai MH; Qian C; Fu HS; Zhao S; Zhou HJ; Cao ZJ; Xie Q
    J Viral Hepat; 2023 Oct; 30(10):803-809. PubMed ID: 37496189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
    Diktas H; Karacaer Z; Özturk II; Cicek H
    Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.